 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              Ankur Drugs & Pharma Ltd has announced that the Board of Directors of the Company at its meeting held on March 29, 2007, has decided to issue 1,055,057 Equity shares on conversion of 4,000 FCCB Bonds of USD 1000.00 each to Grants Investment Ltd - FCCB, Les Cascades Building, Edith Cavell Street, Port Louis, Mauritius (bondholder).
It was further decided that Mr. Purnandu Jain, Chairman and Managing Director or Mr. Girraj Vijayvargiva, Executive Director of the Company be and is hereby authorized to do all the matters related to the above - mentioned issue.
Shares of the company were trading down by Rs.2.25 or 1.10% at Rs.203 on volume of 2750 shares.